. 2017 Mar 13;36(28):4025–4036. doi: 10.1038/onc.2017.43

Table 1. Proportion of tumours (percent) in patients with the hyperparathyroidism-jaw tumour (HPT-JT) syndrome and Cdc73 ^+/− mice.

Tumour	HPT-JT patients	Cdc73^+/− mice (⩾18 months)
Parathyroid	82% adenoma (108/132)¹ >15% carcinoma (20/132)^{1, 9}	68% overall 25% adenoma 75% atypical adenoma
Mandible	33% ossifying fibroma (67/205)⁹	0%
Uterus	74% overall (20/27)^{7, 9} 53% adenomyosis (8/15) 33% adenofibroma (5/15) 27% endometrial hyperplasia (4/15) 27% leiomyoma (4/15) 13% adenosarcoma (2/15)	33% overall 100% endometrial cysts 25% endometrial hyperplasia 13% adenofibroma 13% adenomyoma
Kidney	16% hamartoma (21/132)⁵ <2% Wilms' tumour (3)⁴	0%
Thyroid	<2% Papillary thyroid carcinoma (2)⁷ <1% Hurthle cell adenoma (1)⁸	0%
Pancreas	<1% Adenocarcinoma (1)⁸	0%
Testis	<1% Mixed germ cell tumour (1)⁸	0%

Table 1. Proportion of tumours (percent) in patients with the hyperparathyroidism-jaw tumour (HPT-JT) syndrome and Cdc73 +/− mice.